Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
AtriCure
ATRC
$2.51B
| $1.06M | ﹤0.01% |
19,012
-2,571
| -12% | -$111K |
|
1477
Upwork
UPWK
$1.07B
| $1.06M | ﹤0.01% |
+30,624
| New | +$876K |
|
1478
Horace Mann Educators
HMN
$2.07B
| $1.06M | ﹤0.01% |
+25,118
| New | +$967K |
|
1479
CBIZ
CBZ
$2.96B
| $1.05M | ﹤0.01% |
39,633
-2,128
| -5% | -$52.4K |
|
|
CIM
1480
Chimera Investment
CIM
$973M
| $1.05M | ﹤0.01% |
34,246
-14,266
| -29% | -$413K |
|
1481
Tandem Diabetes Care
TNDM
$1.55B
| $1.05M | ﹤0.01% |
11,037
+3,130
| +40% | +$323K |
|
|
QTS
1482
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.05M | ﹤0.01% |
16,977
-11,020
| -39% | -$689K |
|
1483
Cardlytics
CDLX
$25.2M
| $1.05M | ﹤0.01% |
734
-232
| -24% | -$247K |
|
1484
Datadog
DDOG
$81.1B
| $1.05M | ﹤0.01% |
+10,701
| New | +$1.07M |
|
1485
Community Trust Bancorp
CTBI
$1.39B
| $1.05M | ﹤0.01% |
28,222
-240
| -0.8% | -$8.12K |
|
|
ITCI
1486
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.04M | ﹤0.01% |
32,835
-18,813
| -36% | -$494K |
|
|
FSP
1487
Franklin Street Properties
FSP
$48.2M
| $1.04M | ﹤0.01% |
238,334
+12,016
| +5% | +$53K |
|
1488
Intercorp Financial Services
IFS
$6.07B
| $1.04M | ﹤0.01% |
+32,176
| New | +$836K |
|
1489
Onto Innovation
ONTO
$17.3B
| $1.04M | ﹤0.01% |
21,873
-5,264
| -19% | -$211K |
|
|
MIME
1490
DELISTED
Mimecast Limited
MIME
| $1.04M | ﹤0.01% |
18,284
+917
| +5% | +$42.4K |
|
1491
WEX
WEX
$6.93B
| $1.04M | ﹤0.01% |
5,178
-45,612
| -90% | -$7.67M |
|
1492
Alpha and Omega Semiconductor
AOSL
$783M
| $1.04M | ﹤0.01% |
43,853
+17,843
| +69% | +$364K |
|
1493
CEVA Inc
CEVA
$751M
| $1.04M | ﹤0.01% |
22,774
+6,141
| +37% | +$252K |
|
1494
Dine Brands
DIN
$457M
| $1.04M | ﹤0.01% |
17,867
-6,653
| -27% | -$404K |
|
|
FPRX
1495
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.04M | ﹤0.01% |
60,892
-160,485
| -72% | -$2.01M |
|
1496
Dorman Products
DORM
$3.89B
| $1.03M | ﹤0.01% |
11,911
+6,329
| +113% | +$587K |
|
1497
Gorman-Rupp
GRC
$2.06B
| $1.03M | ﹤0.01% |
31,605
+2,058
| +7% | +$68.2K |
|
|
CYBE
1498
DELISTED
Cyberoptics Corp
CYBE
| $1.03M | ﹤0.01% |
45,229
+19,938
| +79% | +$567K |
|
1499
Twist Bioscience
TWST
$8.83B
| $1.02M | ﹤0.01% |
7,202
+2,225
| +45% | +$247K |
|
|
WW
1500
DELISTED
WW International
WW
| $1.02M | ﹤0.01% |
41,673
-604,681
| -94% | -$15.7M |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.